Treatment of PSA only Recurrence of Prostate Cancer After Prior Local Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|7|785-798

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.7, 2006-03, pp. : 785-798

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

By McKay Rana R.   Gray Kathryn P.   Hayes Julia H.   Bubley Glenn J.   Rosenberg Jonathan E.   Hussain Arif   Kantoff Philip W.   Taplin Mary-Ellen  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2603-2611

Blackwell Publishing

Access to resources Recommend Favorite

Local treatment of high risk prostate cancer: Role of surgery and radiation therapy

By Borza Tudor   Kibel Adam S.  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1608-1610

Blackwell Publishing

Access to resources Recommend Favorite

Patterns of recurrence after trimodality therapy for esophageal cancer

By Dorth Jennifer A.   Pura John A.   Palta Manisha   Willett Christopher G.   Uronis Hope E.   D'Amico Thomas A.   Czito Brian G.  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2099-2105

Blackwell Publishing

Access to resources Recommend Favorite

The Role of Chromogranin A (CgA) in Monitoring Patients with Prostate Cancer Under Androgen Deprivation Therapy: Comparison with Prostatic Specific Antigen (PSA)

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 2, 2008-05 ,pp. : 115-119

Bentham Science Publishers

Access to resources Recommend Favorite

Options for prostate cancer after curative treatment failure

By  

Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite